U.S., March 10 -- ClinicalTrials.gov registry received information related to the study (NCT07457008) titled 'Tolerability & Pharmacokinetics of Ginkgolide B Injection: Single- and Multiple-Ascending Doses in Healthy Subjects' on Feb. 26.
Brief Summary: To evaluate the safety and tolerability of multiple intravenous infusions of Ginkgolide B Injection in healthy Chinese participants, as well as to assess the pharmacokinetic (PK) characteristics following single and multiple doses.
Study Start Date: July 01, 2021
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteers
Intervention:
DRUG: The 10mg dose group
The 10mg dose group was prepared with 375ml of 0.9% sodium chloride solution to form different dosage groups, an
DRUG: The 20m...